Research Presentation Session
RPS 602 - Mammography and breast cancer
Lectures
1
RPS 602 - Impact of COVID-19 pandemic on breast imaging practice: results of a survey from an institutional department in north-western Italy
04:58A. Timpani, Turin / Italy
2
RPS 602 - CEM-guided biopsy: an alternative to MRI-guided breast biopsy
05:18R. Alcantara Souza, Barcelona / Spain
3
RPS 602 - The results in patients diagnosed with high-risk breast lesions with image-guided needle biopsy: a multicentre retrospective study
05:00Ö. Aslan, Izmir / Turkey
4
RPS 602 - The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort
05:17J. Peters, Nijmegen / Netherlands
5
RPS 602 - Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single-centre study
04:28M. Montesano, Milan / Italy
6
RPS 602 - Accuracy of volume measurements of tumours seen in mammograms: a simulation study
05:00H. Tomic, Malmö / Sweden
7
RPS 602 - Initial experience of magnetic seed localisation in an Irish breast centre: of particular importance in the COVID era
07:45L. Sweeney, Dublin / Ireland
8
RPS 602 - Quantitative analysis of enhancement parameters of breast cancer on Contrast-Enhanced Spectral Mammography (CESM): correlation with DCE-MRI and prognostic significance
04:20S. Akkaya, Trabzon / Turkey
9
RPS 602 - Identifying potential improvement points in the breast cancer multidisciplinary team meeting to facilitate development of a clinical decision support system – an interview study
05:07L. Koco, Nijmegen / Netherlands
10
RPS 602 - Contrast-Enhanced Spectral Mammography (CESM) guided biopsy - initial clinical experience
06:39A. Kornecki, London / Canada
11
RPS 602 - Comparison of background parenchymal enhancement on contrast-enhanced spectral mammography and breast MR images
06:32E. Luczynska, Rzeszow / Poland
12
RPS 602 - Incidence of malignant disease associated with pregnancy and lactation: a series of cases
05:57F. Mercado Burgos, Santiago / Chile
13
RPS 602 - The diagnostic value of contrast-enhanced 2D mammography in clinical practice
04:39L. Neeter, Maastricht / Netherlands
14
RPS 602 - Sensitivity for the assessment of breast lesions in contrast enhanced spectral mammography (CESM): can we exclude malignancy?
04:09A. Marzogi, Makkah / Saudi Arabia
15
RPS 602 - Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single-centre study
04:28M. Montesano, Milan / Italy